We're Not Using One of Our Best Weapons against Drug-Resistant Microbes
Antimicrobial resistance (AMR) has been hailed as one of the biggest threats to humanity. The number of deaths caused by drug-resistant bacteria is expected to rise from 700,000 to 10 million a year by 2050. But while the challenges of developing new classes of antibiotics and reducing the use and misuse of existing drugs have dominated the headlines, there is a more immediate and complementary solution: vaccines.
Interaction between two immune cell types could be key to better dengue vaccines, study shows
Duke-NUS Medical School
Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of immune cells that plays an important role in the early fight against dengue virus infection.
The world is too complacent about epidemics. Here's how to change
Julie Louise Gerberding
No one can predict exactly when or where the next threat will occur, but as we learned from the 2014 West Africa Ebola virus outbreak, and the ongoing Ebola crisis in the Democratic Republic of the Congo (DRC), we live in a world where infectious disease outbreaks with the potential for tragic consequences are a certainty.
Australian scientists work to put bite on mosquito-bourne Zika virus
Dr Prasad Paradkar, a senior research scientist with the CSIRO, has been leading a team working with University of California San Diego to genetically engineer Zika-resistant mosquitoes. Dr Paradkar said currently Zika was being fought with insecticide against the mosquitoes, but there needed to be a more complete solution.
Deadly drug-resistant TB a 'blinking red' worldwide threat: Global Fund head Peter Sands
Deadly, drug-resistant tuberculosis - as lethal as Ebola and tough to treat in even the best hospitals - is a "blinking red" worldwide threat, the head of a global health fund warned in an interview. The Global Fund to Fight AIDS, Tuberculosis and Malaria is on a mission to eradicate the three epidemics and plans to spend around US$12 billion on it over the next three years.
Experts Meet in New Delhi to 'Step Up the Fight' Against Malaria and Drug Resistance
The Asia Pacific Leaders' Malaria Alliance (APLMA) convened a panel of senior officials today in New Delhi to discuss the global fight to end malaria, outlining strategies to improve collaboration, increase investment and identify innovative approaches to eliminate the disease and stop drug-resistance.
Scientists from Australia's national science agency CSIRO and the University of California San Diego have engineered mosquitoes to be resistant to spreading the devastating Zika virus.
Detailed in a paper published today in PNAS, the Aedes aegypti mosquitoes were engineered by the university and tested by CSIRO in partnership with other research organisations. "Our study found the mosquitoes with an anti-Zika gene were unable to pick up Zika when they fed, so they were incapable of spreading the virus to anybody else," CSIRO Senior Research Scientist and paper co-author Dr Prasad Paradkar said.
The Importance of Wildlife Disease Monitoring as Part of Global Surveillance for Zoonotic Diseases: The Role of Australia
Rupert Woods, et al.,
Strong cooperative links and coordination mechanisms exist between the human (public health) and animal arms of the health system in Australia. Wildlife is included in this system. The risks to Australia posed by diseases with wildlife as part of their epidemiology will almost certainly become greater with changing land use and climate change and as societal attitudes bring wildlife, livestock and people into closer contact. Animal and human health practitioners are encouraged to consider wildlife in their day to day activities and to learn more about Australia’s system and how they can become more involved by visiting www.wildlifeheathaustralia.com.au.
No Cases of Latent Tuberculosis Reactivation Seen Following Hematopoietic Cell Transplantation
The risk of latent tuberculosis infection (LTBI) reactivation following hematopoietic cell transplantation (HCT) may be lower than previously thought, according to an article published in Clinical Infectious Diseases. In this retrospective cohort study, researchers assessed 2531 patients who had undergone autologous or allogeneic HCT between 2010 and 2015.
Q&A: WHO's new Western Pacific director on vaccine hesitancy, UHC
Jenny Lei Ravelo
A hotspot for infectious diseases, the Asia and Pacific region is currently facing a measles outbreak in parts of the Philippines and a re-emergence of polio in Papua New Guinea. This is part of the reason Dr. Takeshi Kasai, the new regional director of the World Health Organization’s Western Pacific office, emphasizes preparedness as a key priority.